Nipro Corp
TSE:8086
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1 081.5
1 470
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Nipro Corp
Unrealized Security Profit/Loss
Nipro Corp
Unrealized Security Profit/Loss Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Unrealized Security Profit/Loss | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Nipro Corp
TSE:8086
|
Unrealized Security Profit/Loss
ÂĄ9.3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Hoya Corp
TSE:7741
|
Unrealized Security Profit/Loss
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
H
|
Hogy Medical Co Ltd
TSE:3593
|
Unrealized Security Profit/Loss
ÂĄ2.6B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-1%
|
|
Shofu Inc
TSE:7979
|
Unrealized Security Profit/Loss
ÂĄ4.4B
|
CAGR 3-Years
9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
||
Menicon Co Ltd
TSE:7780
|
Unrealized Security Profit/Loss
ÂĄ257m
|
CAGR 3-Years
42%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
||
Mani Inc
TSE:7730
|
Unrealized Security Profit/Loss
ÂĄ11m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-52%
|
CAGR 10-Years
-36%
|
Nipro Corp
Glance View
Nipro Corp. engages in the manufacture and sale of medical equipment, pharmaceutical products, and glass products. The company is headquartered in Osaka, Osaka-Fu and currently employs 35,251 full-time employees. The firm has three segments. The Medical-Related segment involves in the sale of injections and infusions, artificial organs, high function and dialysis related medical equipment, and diabetes, generics and kits related medicine products in Japan, as well as the sales of medical devices for injection and infusion, artificial organs and diabetes in overseas markets. The Pharmaceutical-Related segment involves in the manufacture and sale of pharmaceuticals. The Pharma Packaging segment sells glass for vials and ampoules as medical glass in Japan, thermos glass for lighting and glass for lighting equipment.
See Also
What is Nipro Corp's Unrealized Security Profit/Loss?
Unrealized Security Profit/Loss
9.3B
JPY
Based on the financial report for Jun 30, 2024, Nipro Corp's Unrealized Security Profit/Loss amounts to 9.3B JPY.
What is Nipro Corp's Unrealized Security Profit/Loss growth rate?
Unrealized Security Profit/Loss CAGR 3Y
-1%
Over the last year, the Unrealized Security Profit/Loss growth was 50%. The average annual Unrealized Security Profit/Loss growth rates for Nipro Corp have been -1% over the past three years .